Alan Levy, MD
Vascular Surgery · Stockbridge, GANPI 1558414276
Payments from drug & device makers
What this record shows
This record is dominated by other: $28,958 of the $39,421 with a category attached, or 73.5%. Angiodynamics, Inc. accounts for 74.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2024 at $18,113 and has fallen 89.4% since, to $1,920 in 2025. Among vascular surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $300.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$29K
- Medtronic$3K
- Endologix LLC$3K
- Lemaitre Vascular, Inc.$1K
- W. L. Gore & Associates, Inc.$687
- Johnson & Johnson$392
- plus $2K from 20 others
What the payments were for
- Consulting fees$2,3906%
- Speaking & faculty fees$2,8007%
- Food & beverage$5,27313%
- Other$28,95873%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 14 | $29,274 |
| Medtronic | 7 | $2,969 |
| Endologix LLC | 17 | $2,711 |
| Lemaitre Vascular, Inc. | 6 | $1,388 |
| W. L. Gore & Associates, Inc. | 8 | $687 |
| Johnson & Johnson | 23 | $392 |
| Bard Peripheral Vascular, Inc. | 10 | $318 |
| Shockwave Medical, Inc | 3 | $264 |
| Philips North America LLC | 7 | $262 |
| Inari Medical, Inc. | 4 | $239 |
| Pfizer | 7 | $176 |
| Penumbra, Inc. | 2 | $151 |
| Veryan Medical Incorporated | 2 | $125 |
| Stryker | 3 | $96 |
| Boston Scientific | 2 | $58 |
| Mozarc Medical US LLC | 3 | $58 |
| Abbott | 3 | $49 |
| Argon Medical Devices, Inc. | 2 | $41 |
| Convatec Inc. | 1 | $25 |
| Laminate Medical Technologies Inc. | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Neuros Medical, Inc. | 1 | $22 |
| AbbVie | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| BD | 1 | $17 |
| Silk Road Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$28,958
- VenaSeal$2,800
- AFX$1,968
- ARTEGRAFT VASCULAR GRAFT$1,190
- GORE VIABAHN VBX Balloon Expandable Endo$350
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$247
- GORE VIABAHN Endoprosthesis$168
- FlowTriever$134
- ClotTriever$134
- Penumbra System$130
- VIABAHN VBX Balloon Expandable Endoprosthesis$125
- PROCOL$124
- Alto Abdominal Stent Graft System$121
- BioMimics 3D Vascular Stent System$103
How this compares
$39,421 in reported general payments places this provider in the 90th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 54 | $64,172 |
| EliquisApixaban | 52 | $39,997 |
| Cilostazol | 137 | $1,879 |
| Pentoxifylline | 51 | $1,491 |
| ClopidogrelClopidogrel Bisulfate | 70 | $989 |
| Gabapentin | 20 | $167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $152 |
| Tramadol Hcl | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $392 | $64,17254 claims |
| PfizerEliquis | $176 | $39,99752 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Stockbridge
- Paul JonesStockbridge$24K
- Siddharth PatelAtlanta$303K
- Juan AyerdiColumbus$130K
- Albert RichardsonThomasville$103K
- Walaya Methodius-RayfordAtlanta$79K
- Eric MartinFort Gordon$64K
- William JordanAugusta$64K
- Alykhan LalaniMarietta$64K
- Charles MoomeyGainesville$52K
- Suman AnnambhotlaGainesville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.